Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Pfizer

Don't wait for a holiday surge. Now is a good time to get your flu and COVID-19 vaccines

Health officials say it's important to get flu and COVID-19 vaccines ahead of the holidays when respiratory bugs tend to spread

The Independent UK

Is This High-Yield Dividend Stock a Buy After Earnings?

This pharmaceutical giant's Q3 numbers came in ahead of Street estimates.

Barchart

Amgen 'Laser-Focused' On Its Weight-Loss Shot As New Rival Pfizer Follows, Says CFO

Amgen is focusing deeply on its efforts to treat obesity, the CFO said Wednesday. Amgen stock rose early Thursday.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Are Wall Street Analysts Predicting Pfizer Stock Will Climb or Sink?

Despite Pfizer’s underperformance relative to the broader market over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

Stock Market Today: Nasdaq Hits New High Ahead of Alphabet Earnings

The Google parent is one of several mega caps reporting earnings this week, with results due out after Tuesday's close.

Kiplinger

Why Pfizer Stock Is Lower After a Beat-and-Raise Quarter

Pfizer stock is down Tuesday even after the drugmaker reported higher-than-expected Q3 earnings and raised its full-year outlook.

Kiplinger

Hundreds of blood cancer patients to benefit from new Pfizer treatment

Myeloma affects 24,000 people a year in the UK

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Dow Jones Falls Amid Key Data; Nvidia, Tesla Drop Below Buy Points

Stock Market Today: The Dow Jones industrials fell Tuesday amid key data. Nvidia stock and Tesla gave up buy points Monday.

Investors Business Daily

Pfizer Unveils Its Next Black Box In Obesity. It's Taking On Amgen.

Pfizer is taking on Amgen with its next steps in weight loss, the pharma titan said Tuesday as Pfizer stock dipped despite its beat.

Investors Business Daily

Stock Market Today: Stocks mixed as Treasury yields jump; Google on deck

Another leg higher in Treasury bond yields is muting stock gains heading into a busy earnings session on Wall Street.

The Street

Stock Index Futures Tread Water Ahead of U.S. JOLTs Report, Alphabet Earnings on Tap

December S&P 500 E-Mini futures (ESZ24) are up +0.06%, and December Nasdaq 100 E-Mini futures (NQZ24) are up +0.08% this morning as market participants geared up for the latest reading on U.S. job openings while also awaiting a deluge of corporate earnings reports from heavyweight names.

Barchart

Gold price hits fresh record high, as bitcoin also rallies – as it happened

Analysts say gold is benefited from safe-haven demand amid persistent geopolitical tensions, expectations of monetary policy easing, and mounting uncertainty surrounding the US presidential election.

The Guardian - UK

As activist Starboard engages constructively, here’s a potent prescription for Pfizer’s future success under Dr. Bourla’s watch

Pfizer is getting back on track—but an even more potent prescription for success could be in the cards for the pharmaceutical giant under.

Fortune

Starboard Hammers Pfizer Execs For Failing To Deliver On 'Best Pipeline' Promises

Starboard took aim at Pfizer in another blow Tuesday, saying the company has failed to deliver on what it called the "best pipeline" ever.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Nvidia Among Five Best S&P 500 Stocks Today

Pfizer spinoff Kenvue led the S&P 500 on Monday. Nvidia stock was close behind, breaking out to a record high.

Barchart

What to Expect From Pfizer's Q3 2024 Earnings Report

Pfizer is expected to release its fiscal third-quarter earnings later this month, and analysts project a triple-digit profit growth.

Barchart

Should You Follow Activist Investors Into This High-Yield Dividend Stock?

This dividend stock is now on the radar of activist investors, with Starboard eyeing a possible management shakeup.

The Guardian - UK

‘The UK is at the back of the race of turtles’: Sanofi’s boss on the need to develop new medicines

Paul Hudson, the Briton in charge of the French drug firm, is a big believer in the potential of AI to transform healthcare

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Nvidia's 84% Expected Profit Growth Looms Large In S&P 500

Nvidia is expected to boost the S&P 500 Q3 earnings growth rate. Meta Platforms and Alphabet may lift Communications Services earnings.

Barchart

How To Spot Good Value Stocks In A Sea Of Noise

Explore why traditional value investing often falls short and how catalysts can transform undervalued stocks into lucrative investments.

Investors Business Daily

Stock Market Rallies As S&P 500, Dow Hit Highs; Tesla Robotaxi Isn't Hailed, Delta, JPMorgan In Focus: Weekly Review

The stock market had a key week, as the S&P 500 and Dow hit record highs. The Tesla robotaxi failed to wow, but many leaders broke out.

Fortune

Here are the facts that activist critics of Pfizer CEO Albert Bourla are missing, according to a Yale analysis

'Some misleading narratives about Bourla’s leadership that have been put forward have been distinctly unfair,' write Jeff Sonnenfeld and Steven Tian.

Kiplinger

Stock Market Today: Markets Slip on Hot Inflation Print, Layoff News

Economic data continues to complicate expectations for Federal Reserve rate cuts.

Investors Business Daily

Pfizer Skids After Former Execs Flip On Starboard; Activist Investor Says They Were Coerced

Pfizer stock skidded Thursday after former executives Ian Read and Frank D'Amelio sided with the drugmaker over activist investor Starboard.

Barchart

3 High-Yield Stocks for Growing Dividend Income

Each of these companies boasts a solid track record of paying and raising dividends, with yields exceeding 5%.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations